Cellbyte Secures $2.75M Funding to Transform Drug Launch Processes
Cellbyte, an innovative AI-native platform, has raised $2.75 million in seed funding aimed at expediting drug launches for pharmaceutical companies. The funding round was led by Frontline Ventures and included…